These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6225312)

  • 1. [Effects of nicardipine on vertebral vascular resistance in anesthetized dogs and spontaneous activity in mice].
    Wei JY; Su ML; Duan MJ; Chen YH; Liu XM
    Zhongguo Yao Li Xue Bao; 1983 Jun; 4(2):97-100. PubMed ID: 6225312
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of coronary dilating effects of Ki1769, a new K channel opener of the pyridinecarboximidamide type, and nifedipine in anesthetized dogs.
    Yokoyama T; Kaneta S; Miwa A; Tanaka Y; Izumi H; Izawa T; Ogawa N
    Arch Int Pharmacodyn Ther; 1994; 327(2):194-203. PubMed ID: 7979828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nicardipine, a new dihydropyridine vasodilator, on coronary circulation and ischemia-induced conduction delay in dogs.
    Nakaya H; Kanno M
    Arzneimittelforschung; 1982; 32(6):626-9. PubMed ID: 7202368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasodilator and hypotensive effects of the optical isomers of nicardipine (YC-93), a new Ca2+-antagonist.
    Takenaka T; Miyazaki I; Asano M; Higuchi S; Maeno H
    Jpn J Pharmacol; 1982 Aug; 32(4):665-70. PubMed ID: 7131951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of calcium influx in rabbit aorta by nicardipine hydrochloride (YC-93).
    Terai M; Takenaka T; Maeno H
    Biochem Pharmacol; 1981 Feb; 30(4):375-8. PubMed ID: 7213424
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of nicardipine on the cross-perfused canine atrium.
    Watanabe H; Furukawa Y; Iwatsuki K; Chiba S
    Jpn J Pharmacol; 1981 Oct; 31(5):725-30. PubMed ID: 7311168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nicardipine: vascular compliance and development of genetic hypertension in the SHR rat].
    Maury M; Freslon JL; Richer C; Bucher B; Stoclet JC; Giudicelli JF
    J Pharmacol; 1984; 15(2):157-67. PubMed ID: 6738074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic responses to nifedipine in dogs anesthetized with halothane.
    Tosone SR; Reves JG; Kissin I; Smith LR; Fournier SE
    Anesth Analg; 1983 Oct; 62(10):903-8. PubMed ID: 6614523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pirozadil on cerebral blood flow in anesthetized dogs.
    Roca J; Grau M; Balasch J
    Methods Find Exp Clin Pharmacol; 1981; 3(6):397-401. PubMed ID: 7329165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Membrane transport of anticancer drugs--potentiation of antitumor effect by calcium modifiers and overcoming of drug-resistance].
    Tsuruo T
    Tanpakushitsu Kakusan Koso; 1983 May; 28(6):865-71. PubMed ID: 6611960
    [No Abstract]   [Full Text] [Related]  

  • 11. Nicardipine: protection against brain hypoxia.
    Montero JL; Grau M; Balasch J
    Drugs Exp Clin Res; 1986; 12(5):377-80. PubMed ID: 3720521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement by nifedipine of cholinergic-induced depression of locomotor activity in mice.
    Sansone M; Battaglia M; Pavone F
    Funct Neurol; 1995; 10(4-5):163-7. PubMed ID: 8749042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries.
    Kanda M; Shirahase H; Kurahashi K; Wada K; Nakamura S; Matsui H; Fukata F
    Arzneimittelforschung; 1995 Aug; 45(8):831-5. PubMed ID: 7575741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of intravenous nicardipine during upright exercise in patients with stable angina pectoris.
    Jackson NC; Silke B; Verma SP; Reynolds G; Hafizullah M; Taylor SH
    Postgrad Med J; 1984; 60 Suppl 4():11-6. PubMed ID: 6527973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative coronary vasodilatory effects of nifedipine and niludipine.
    Ogawa K; Wakamasu Y; Ito T; Suzuki T; Yamazaki N
    Arzneimittelforschung; 1981; 31(5):770-3. PubMed ID: 7196733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of magnesium and nicardipine in the cardioplegic solution on the coronary arteries and myocardium].
    Shikano K; Nasu M; Miyamura K; Sakai T; Shomura S
    Rinsho Kyobu Geka; 1984 Sep; 4(5):556-60. PubMed ID: 6522980
    [No Abstract]   [Full Text] [Related]  

  • 17. Immediate and longer-term effects of nicardipine, at rest and during exercise, in patients with coronary artery disease.
    Visser CA; Jaarsma W; Kan G; Lie KI
    Postgrad Med J; 1984; 60 Suppl 4():17-20. PubMed ID: 6527974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Protective effect of nicardipine in an experimental model of transient myocardial ischemia in anesthetized dogs].
    Bongrani S; Schiantarelli P; Acerbi D; Ciampalini G; Ferrari R
    Cardiologia; 1986 Jan; 31(1):55-62. PubMed ID: 3742516
    [No Abstract]   [Full Text] [Related]  

  • 19. Deactivation of the uterus during normal and premature labor by the calcium antagonist nicardipine.
    Csapo AI; Puri CP; Tarro S; Henzl MR
    Am J Obstet Gynecol; 1982 Mar; 142(5):483-91. PubMed ID: 7058850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of effects of nifedipine and nitroglycerin on large and small coronary arteries and cardiac function in conscious dogs.
    Hintze TH; Vatner SF
    Circ Res; 1983 Feb; 52(2 Pt 2):I139-46. PubMed ID: 6403258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.